Documente Academic
Documente Profesional
Documente Cultură
Finolex Industries
BUY
INDUSTRY PIPES
Betting on volume growth
2QFY18 was a muted quarter for Finolex Industries Equipped with a strong brand, the ability to
CMP (as on 13 Nov 17) Rs 696 (Finolex), as (1) Despite volume growth (23% YoY in backward integrate, a strong balance sheet, and high
Target Price Rs 861 Pipes & Fittings and 2% YoY in PVC resin), overall return ratios, we believe that Finolex offers several
revenues grew marginally by 4% YoY to Rs 4.7bn, and years of compounding potential. Maintain BUY. Our
Nifty 10,225 (2) Realisation per tonne declined in both segments SOTP TP stands at Rs 861.
Sensex 33,034 (-2% YoY in PVC resin to ~68/kg and -16% YoY in
KEY STOCK DATA Pipes & Fittings to ~Rs 90/kg) , (3) The plant Steady ramp-up in capacity: Finolexs cumulative Pipes
shutdown in Q2FY18 led to a ~Rs 360mn increase in & Fittings capacity stands at 290k MT. The company
Bloomberg FNXP IN
costs, which weighed on the companys overall plans to add 150k MT capacity, and the complete
No. of Shares (mn) 124
performance. EBIT margins for PVC resin fell 642bps benefit of the same is expected to accrue by 2020. Of
MCap (Rs bn) / ($ mn) 86/1,318 this, almost 50k MT could be used for CPVC. The
YoY to 13.6%, and EBIT margins for Pipes & Fittings
6m avg traded value (Rs mn) 43 estimated outlay for this expansion is Rs 2.5bn over
fell 295bps to 3.2%. While absolute EBITDA de-grew
STOCK PERFORMANCE (%) by ~43% YoY, margins declined 861 bps to 10.4%. FY17-20, of which Finolex has invested Rs 1.2bn, and
52 Week high / low Rs 756/381 PAT de-grew by ~45% YoY to Rs 283mn. the remaining will be invested in the next two years.
3M 6M 12M
Going forward, we believe there are multiple triggers Distribution: Finolex enjoys a pan-India presence, with
Absolute (%) 21.0 17.9 60.3
for Finolexs volume and profitability growth. These ~850 dealers and ~18K retail touch points. Almost 50%
Relative (%) 15.2 8.5 37.1 are (1) Govts focus on the agriculture and housing of the dealers are present in rural areas, and the rest in
SHAREHOLDING PATTERN (%) sectors, (2) Company envisages to increase the share urban. The companys operations are focused on South
of non-agri demand in its revenue pie (from 30% and West India, which contribute 70%+ to the top-line.
Promoters 52.5
currently to ~50% over four to five years), (3) A Finolex had added 150 SKUs for CPVC pipes.
FIs & Local MFs 8.1
FPIs 4.2 ramp-up of higher-margin CPVC volumes over the Near-term outlook: Ramp-up in the CPVC business,
near term, and (4) GST tailwinds. focus on non-agri (with higher margin fittings).
Public & Others 35.2
Source : BSE Financial Summary
(Rs mn) 2QFY18 2QFY17 YoY (%) 1QFY18 QoQ (%) FY17 FY18E FY19E FY20E
Net Sales 4,753 4,568 4 7,307 (35) 29,876 32,014 36,238 40,837
EBIDTA 496 870 (43) 1,306 (62) 5,630 5,019 5,933 6,977
APAT 283 513 (45) 798 (65) 3,522 3,081 3,693 4,395
Diluted adj. EPS (Rs/sh) 2.3 4.1 (45) 6.4 (65) 28.4 24.8 29.8 35.4
Basanth Patil P/E (x) 24.5 28.0 23.4 19.7
basanth.patil@hdfcsec.com RoE (%) 18.2 13.0 14.5 15.9
+91-22-6171-7319 Source: Company, HDFC sec Inst Research
HDFC securities Institutional Research is also available on Bloomberg HSLB <GO> & Thomson Reuters
FINOLEX INDUSTRIES: RESULTS REVIEW 2QFY18
Margin Analysis
2QFY18 2QFY17 YoY (bps) 1QFY18 QoQ (bps)
Material Expenses % Net Sales 65.9 58.3 764.8 66.8 (89.6)
RM spread (PVC/EDC delta) Employee Expenses % Net Sales 6.0 5.6 43.6 3.9 209.8
was at ~700 USD/MT in Other Expenses % Net Sales 17.6 17.1 52.5 11.4 624.3
2QFY18 EBITDA Margin (%) 10.4 19.0 (860.9) 17.9 (744.4)
Tax Rate (%) 31.9 34.9 (292.5) 31.8 12.4
APAT Margin (%) 6.0 11.2 (528.2) 10.9 (496.6)
Source: Company, HDFC sec Inst Research
Page | 2
FINOLEX INDUSTRIES: RESULTS REVIEW 2QFY18
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Q3FY16
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
We expect the proportion of Source: Company, HDFC sec Inst Research Source: Company, HDFC sec Inst Research
higher-margin fittings to
gradually increase in the
overall volumes of the Trend In Revenue Of Pipes & Fittings Quarterly Trend In EBIT Margin Of Pipes & Fittings
company Revenue from Pipes & Fittings YoY growth (%) - RHS Pipes & Fittings - Segmental EBIT Margin (%) RHS
Rs mn Rs mn
8,000 16% 700 10%
6,981 6,892 9%
7,000 6,310 6,581 14% 600
8%
6,000 12% 500 7%
5,000 4,446 4,250 10% 6%
4,073 4,100 400
4,000 8% 5%
In FY17, the average EBIT 300 4%
3,000 6%
margin for Pipes & Fittings 2,000 4%
200 3%
2%
stood at ~8% 1,000 2% 100
1%
0 0% 0 0%
Q3FY16
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Q3FY16
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Source: Company, HDFC sec Inst Research Source: Company, HDFC sec Inst Research
Page | 3
FINOLEX INDUSTRIES: RESULTS REVIEW 2QFY18
Q3FY16
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Q3FY16
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Source: Company, HDFC sec Inst Research Source: Company, HDFC sec Inst Research
600 10%
400
5%
200
0 0%
Q3FY16
Q4FY16
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Page | 4
FINOLEX INDUSTRIES: RESULTS REVIEW 2QFY18
Financials
The top line is expected to Key Assumptions
grow at ~11% CAGR over FY16 FY17 FY18E FY19E FY20E
FY17-20E Volumes (MT)
Pipes and fittings 208,763 209,339 236,958 266,814 297,986
% YoY 12.4% 0.3% 13.2% 12.6% 11.7%
PVC resin 248,177 235,644 252,558 271,364 288,995
% YoY 2.1% -5.1% 7.2% 7.4% 6.5%
Peer Valuations
Mcap CMP TP P/E (x) EV/EBITDA (x) P/BV (x)
Rating
(Rs bn) (Rs) (Rs) FY18E FY19E FY20E FY18E FY19E FY20E FY18E FY19E FY20E
Supreme Industries 142 1,118 NR - 50.3 58.4 66.5 18.9 15.6 13.5 7.5 6.5 5.7
Astral Poly Technik 92 765 NR - 50.6 37.4 33.0 28.2 22.5 19.4 9.0 7.4 6.2
Finolex Industries 86 696 BUY 861 28.0 23.4 19.7 17.3 14.6 12.3 3.5 3.3 3.0
The EBIT margin for PVC Source: HDFC sec Inst Research
segment stood at ~20% in
FY17, mainly on account of Change In Estimates
favourable PVC/EDC spread. Previous New % Chg
Rs mn
FY18E FY19E FY18E FY19E FY18E FY19E
Net Sales 28,544 32,185 32,014 36,238 12% 13%
EBIT 4,863 5,720 4,444 5,340 -9% -7%
APAT 3,189 3,796 3,081 3,693 -3% -3%
Source: HDFC sec Inst Research
Page | 5
FINOLEX INDUSTRIES: RESULTS REVIEW 2QFY18
Page | 6
FINOLEX INDUSTRIES: RESULTS REVIEW 2QFY18
RECOMMENDATION HISTORY
Finolex Inds TP Date CMP Reco Target
900 8-May-17 562 BUY 760
29-May-17 598 BUY 765
800
13-Nov-17 696 BUY 861
700
600
500
400
Feb-17
Jul-17
Sep-17
Nov-16
Nov-17
Jun-17
May-17
Dec-16
Mar-17
Oct-17
NEUTRAL : Where the stock is expected to deliver (-)10% to 10% returns over the next 12 month period
SELL : Where the stock is expected to deliver less than (-)10% returns over the next 12 month period
Page | 8
FINOLEX INDUSTRIES: RESULTS REVIEW 2QFY18
Disclosure:
I, Basanth Patil, MBA, author and the name subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL
has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific
recommendation(s) or view(s) in this report.
Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have
beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities
Ltd. or its associate does not have any material conflict of interest.
Any holding in stock No
HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475.
Disclaimer:
This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon
information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its
accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their
securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments.
This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or
other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement
within such jurisdiction.
If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced,
distributed or published for any purposes without prior written approval of HSL.
Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition,
investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk.
It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail
and/or its attachments.
HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in
any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or
lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report,
including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc.
HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other
deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report.
HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve
months.
HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in respect of managing or
co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business.
HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor
Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or
brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any
compensation/benefits from the subject company or third party in connection with the Research Report.
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022)
2496 5066
Compliance Officer: Binkle R. Oza Email: complianceofficer@hdfcsec.com Phone: (022) 3045 3600
HDFC Securities Limited, SEBI Reg. No.: NSE-INB/F/E 231109431, BSE-INB/F 011109437, AMFI Reg. No. ARN: 13549, PFRDA Reg. No. POP: 04102015, IRDA Corporate Agent License No.: HDF 2806925/HDF
C000222657, SEBI Research Analyst Reg. No.: INH000002475, CIN - U67120MH2000PLC152193
Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing.
Page | 9
FINOLEX INDUSTRIES: RESULTS REVIEW 2QFY18
HDFC securities
Institutional Equities
Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park,
Senapati Bapat Marg, Lower Parel, Mumbai - 400 013
Board : +91-22-6171-7330 www.hdfcsec.com
Page | 10